Physician
Southwest Medical Associates, LLC
Southwest Medical Associates, LLC was paid $41.40M by Medicaid between Jan 2018 and Dec 2024, across 227 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 17% of everything it billed.
33Billing provider infoSOUTHWEST MEDICAL ASSOCIATES, LLC
ALBUQUERQUE, NM 87109
ALBUQUERQUE, NM 87109
33aNPI1164491072assigned 03/14/2006
33bProvider typeFamily Medicine Physician
28Total paid$41.40M
24GClaims758,139
24DCodes billed227
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in New Mexico
Rank by total paid#2 of 148
Median peer was paid$167K
This provider vs. median247×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official PETROVICH, STEPHEN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 53,967 | $3.30M | |
| 2019 | 83,498 | $4.93M | |
| 2020 | 101,262 | $6.35M | |
| 2021 | 99,094 | $6.51M | |
| 2022 | 88,177 | $6.07M | |
| 2023 | 175,800 | $7.14M | |
| 2024incomplete | 156,341 | $7.11M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 85,225 | 82,754 | $7.01M |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 13% | 9,909 | 5,190 | $5.44M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11% | 76,594 | 74,080 | $4.66M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 8.6% | 46,673 | 22,539 | $3.57M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.6% | 17,968 | 17,701 | $2.30M |
| 99223 | Prolong inpt eval add15 m | 5.3% | 15,054 | 14,577 | $2.19M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 5.0% | 41,006 | 19,136 | $2.07M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.2% | 18,909 | 18,670 | $1.74M |
| 99239 | Hospital discharge day management, more than 30 minutes | 2.9% | 14,817 | 14,290 | $1.22M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.9% | 15,356 | 15,143 | $796K |
| 76801 | 1.6% | 4,240 | 3,945 | $655K | |
| 99222 | Initial hospital care, per day, moderate complexity | 1.6% | 6,059 | 5,890 | $655K |
215 more codes
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.6% | 5,622 | $653K |
| 99490 | Ccm add 20min | 1.5% | 16,422 | $632K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.5% | 4,275 | $626K |
| 64615 | 1.4% | 4,753 | $575K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1.2% | 73,695 | $486K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.0% | 4,076 | $430K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 1,825 | $397K |
| 90461 | <1% | 4,767 | $392K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 8,216 | $341K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 2,689 | $321K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 2,562 | $270K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 9,214 | $199K |
| 99385 | <1% | 936 | $169K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,340 | $138K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 585 | $134K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,159 | $121K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 2,102 | $119K |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | <1% | 61 | $113K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 419 | $111K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 2,947 | $109K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 960 | $98K |
| 97803 | <1% | 1,579 | $90K | |
| 93458 | <1% | 434 | $85K | |
| 90686 | <1% | 7,289 | $82K | |
| 59025 | Fetal non-stress test | <1% | 2,406 | $80K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,220 | $78K |
| 95811 | <1% | 733 | $77K | |
| 64405 | <1% | 755 | $73K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 695 | $68K |
| 47563 | <1% | 123 | $63K | |
| 99205 | Prolong outpt/office vis | <1% | 347 | $62K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 584 | $62K |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | <1% | 181 | $60K |
| 20610 | <1% | 953 | $53K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 576 | $51K |
| 99497 | <1% | 1,294 | $49K | |
| 81025 | <1% | 5,434 | $47K | |
| 94729 | <1% | 1,251 | $47K | |
| 64400 | <1% | 317 | $46K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 444 | $44K |
| 90715 | <1% | 1,231 | $42K | |
| 93295 | <1% | 1,383 | $41K | |
| 64450 | <1% | 714 | $41K | |
| 99386 | <1% | 225 | $40K | |
| 92557 | <1% | 1,187 | $39K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,474 | $39K |
| 93297 | <1% | 2,961 | $39K | |
| 43235 | <1% | 253 | $38K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 757 | $38K |
| 97802 | <1% | 414 | $36K | |
| 94726 | <1% | 960 | $35K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 313 | $35K |
| 99443 | <1% | 327 | $35K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,882 | $33K |
| 99442 | <1% | 371 | $33K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,855 | $31K |
| 90677 | <1% | 112 | $30K | |
| J1439 | Injection, ferric carboxymaltose, 1 mg | <1% | 30 | $27K |
| 99383 | <1% | 176 | $26K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 523 | $26K |
| 94060 | <1% | 712 | $26K | |
| 99152 | <1% | 1,285 | $24K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,423 | $24K |
| 59510 | <1% | 12 | $24K | |
| 99381 | <1% | 123 | $22K | |
| 20553 | <1% | 731 | $21K | |
| 99439 | <1% | 337 | $20K | |
| 90670 | <1% | 3,209 | $19K | |
| 99220 | <1% | 180 | $19K | |
| 93000 | <1% | 1,646 | $18K | |
| 92567 | <1% | 1,239 | $17K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 56 | $16K |
| 96127 | <1% | 1,918 | $16K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 480 | $15K |
| 69210 | <1% | 370 | $14K | |
| 95117 | <1% | 1,501 | $14K | |
| 87428 | <1% | 193 | $14K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 432 | $14K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 239 | $12K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 258 | $12K |
| 95886 | <1% | 113 | $12K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,359 | $12K |
| 93294 | <1% | 739 | $11K | |
| 49083 | <1% | 80 | $11K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 104 | $11K |
| 91200 | <1% | 827 | $11K | |
| 99406 | <1% | 1,118 | $10K | |
| 73630 | <1% | 547 | $10K | |
| 51798 | <1% | 978 | $10K | |
| 76830 | Ultrasound, transvaginal | <1% | 102 | $10K |
| 93018 | <1% | 973 | $10K | |
| 99382 | <1% | 65 | $10K | |
| 99384 | <1% | 59 | $9K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 342 | $9K |
| 20551 | <1% | 231 | $9K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 670 | $9K |
| 90678 | <1% | 25 | $8K | |
| 90661 | <1% | 261 | $8K | |
| 93793 | <1% | 919 | $7K | |
| 90698 | <1% | 2,270 | $7K | |
| 90732 | <1% | 77 | $7K | |
| 76820 | <1% | 210 | $7K | |
| 31231 | <1% | 52 | $6K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 68 | $6K |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | <1% | 13 | $6K |
| 95806 | <1% | 99 | $6K | |
| 93248 | <1% | 242 | $5K | |
| 99496 | <1% | 30 | $5K | |
| 93298 | <1% | 294 | $5K | |
| 93016 | <1% | 327 | $5K | |
| 95885 | <1% | 64 | $5K | |
| 74240 | <1% | 76 | $5K | |
| 92504 | <1% | 216 | $5K | |
| 90651 | <1% | 280 | $5K | |
| 94010 | <1% | 197 | $5K | |
| 92551 | <1% | 358 | $4K | |
| 99221 | <1% | 49 | $4K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,140 | $4K |
| 98968 | <1% | 114 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 461 | $4K |
| 0011A | <1% | 101 | $3K | |
| 99173 | <1% | 518 | $3K | |
| 93296 | <1% | 354 | $3K | |
| 59899 | <1% | 26 | $3K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 13 | $3K |
| 43244 | <1% | 14 | $3K | |
| 0012A | <1% | 71 | $3K | |
| 43264 | <1% | 12 | $3K | |
| 31575 | <1% | 30 | $3K | |
| 85610 | <1% | 718 | $3K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 96 | $2K |
| 90680 | <1% | 1,968 | $2K | |
| 95911 | <1% | 13 | $2K | |
| 99219 | <1% | 30 | $2K | |
| 95251 | <1% | 65 | $2K | |
| 76536 | <1% | 69 | $2K | |
| 96367 | <1% | 62 | $2K | |
| 96130 | <1% | 14 | $2K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 12 | $2K |
| 11102 | <1% | 26 | $2K | |
| 99441 | <1% | 42 | $2K | |
| 96131 | <1% | 14 | $2K | |
| 96121 | <1% | 12 | $2K | |
| 0031A | <1% | 42 | $2K | |
| 93299 | <1% | 69 | $2K | |
| 95923 | <1% | 12 | $1K | |
| 95819 | <1% | 13 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 872 | $1K |
| 73564 | <1% | 56 | $1K | |
| 99195 | <1% | 12 | $1K | |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 12 | $1K |
| 96161 | <1% | 185 | $1K | |
| 20605 | <1% | 35 | $1K | |
| 99401 | <1% | 35 | $974.12 | |
| 96116 | <1% | 12 | $922.87 | |
| 73560 | <1% | 38 | $843.95 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 97 | $756.96 |
| 81002 | <1% | 583 | $742.01 | |
| 73562 | <1% | 41 | $729.78 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 67 | $702.73 |
| 96136 | <1% | 14 | $681.03 | |
| 76937 | <1% | 72 | $633.43 | |
| 96137 | <1% | 13 | $628.40 | |
| 81003 | <1% | 642 | $607.54 | |
| 71271 | <1% | 12 | $599.97 | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 199 | $571.36 |
| 17000 | <1% | 12 | $564.12 | |
| 93925 | <1% | 29 | $548.17 | |
| 90707 | <1% | 92 | $527.46 | |
| 90633 | <1% | 713 | $507.56 | |
| 90688 | <1% | 83 | $504.48 | |
| 71250 | <1% | 13 | $494.95 | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 38 | $417.83 |
| 93244 | <1% | 27 | $411.25 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 42 | $390.95 |
| 90744 | <1% | 1,008 | $371.88 | |
| 82962 | <1% | 143 | $347.35 | |
| 90710 | <1% | 308 | $323.54 | |
| L3040 | Foot, arch support, removable, premolded, longitudinal, each | <1% | 12 | $293.97 |
| 90474 | <1% | 12 | $231.80 | |
| 29540 | <1% | 17 | $229.38 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 13 | $212.65 |
| 71045 | Radiologic examination, chest; single view | <1% | 23 | $201.01 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 167 | $198.35 |
| 72170 | <1% | 14 | $191.63 | |
| 99407 | <1% | 13 | $177.57 | |
| 74420 | <1% | 14 | $166.69 | |
| 90723 | <1% | 81 | $145.80 | |
| 90648 | <1% | 354 | $145.80 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 312 | $69.09 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 149 | $13.72 |
| 3080F | 0% | 1,965 | $0.00 | |
| 3008F | 0% | 60,179 | $0.00 | |
| 3079F | 0% | 11,242 | $0.00 | |
| 3074F | 0% | 38,925 | $0.00 | |
| 1123F | 0% | 11,057 | $0.00 | |
| 3075F | 0% | 3,429 | $0.00 | |
| 3044F | 0% | 2,826 | $0.00 | |
| 90716 | 0% | 83 | $0.00 | |
| 90696 | 0% | 41 | $0.00 | |
| Q0247 | Injection, sotrovimab, 500 mg | 0% | 13 | $0.00 |
| 1111F | 0% | 54 | $0.00 | |
| 91303 | 0% | 40 | $0.00 | |
| 3052F | 0% | 16 | $0.00 | |
| 3078F | 0% | 34,252 | $0.00 | |
| 3077F | 0% | 4,599 | $0.00 | |
| 90685 | 0% | 222 | $0.00 | |
| 90700 | 0% | 62 | $0.00 | |
| 3725F | 0% | 13 | $0.00 | |
| 3046F | 0% | 91 | $0.00 | |
| 90734 | 0% | 73 | $0.00 | |
| 90756 | 0% | 55 | $0.00 | |
| 90672 | 0% | 62 | $0.00 | |
| Q0243 | Injection, casirivimab and imdevimab, 2400 mg | 0% | 35 | $0.00 |
| S9470 | Nutritional counseling, dietitian visit | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPETROVICH, STEPHEN (EVP GENERAL COUNSEL)
Parent organizationLOVELACE HEALTH SYSTEMS LLC
| Provider | Location | Paid |
|---|---|---|
| Lovelace Health System, LLC | Albuquerque, NM | $57.71M |
| Lovelace Health System LLC | Albuquerque, NM | $45.27M |
| Lovelace Health System, LLC | Albuquerque, NM | $31.24M |
| Lovelace Health System LLC | Roswell, NM | $20.13M |
| Jacksonville Hospital LLC | Jacksonville, TX | $9.41M |
| Henderson Hospital, LLC | Henderson, TX | $8.52M |
| Athens Hospital, LLC | Athens, TX | $8.32M |
| Etmc Physician Group INC. | Tyler, TX | $8.03M |
| Tyler Regional Hospital LLC | Tyler, TX | $7.94M |
| Lovelace UNM Rehabilitation Hospital LLC | Albuquerque, NM | $6.30M |
| Pocatello Hospital LLC | Pocatello, ID | $6.11M |
| Jacksonville Hospital LLC | Jacksonville, TX | $5.93M |
| Ahs Pryor Hospital, LLC | Pryor, OK | $5.61M |
| Bsa Hospital LLC | Amarillo, TX | $4.96M |
| Pittsburg Hospital LLC | Pittsburg, TX | $4.83M |
| Ahs Claremore Regional Hospital, LLC. | Claremore, OK | $4.81M |
| Ahs Henryetta Hospital LLC | Henryetta, OK | $4.27M |
| Pittsburg Hospital LLC | Pittsburg, TX | $3.98M |
| Topeka Hospital, LLC | Topeka, KS | $3.94M |
| Ahs Pryor Hospital, LLC | Pryor, OK | $3.76M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.